Healthcare Infection Control Practices Advisory Committee (HICPAC); Amended Notice of Meeting, 14946 [2020-05260]

Download as PDF 14946 Federal Register / Vol. 85, No. 51 / Monday, March 16, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC); Amended Notice of Meeting Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE–20– 001, Evaluating Practiced-Based Programs, Policies, and Practices From CDC’s Rape Prevention Education Program; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC); March 5, 2020, from 9:00 a.m. to 5:00 p.m., EST, and March 6, 2020, from 9:00 a.m. to 12:00 p.m., EST. Centers for Disease Control and Prevention, Global Communications, Center, Building 19, Auditorium B, 1600 Clifton Road NE, Atlanta, Georgia 30329–4027, and teleconference at 1– 800–857–2850, passcode: 2622054, which was published in the Federal Register on January 6, 2020 Volume 85, Number 3, page 506. The meeting will now be held via teleconference only on March 5, 2020, from 9:00 a.m. to 1:00 p.m., EST. A total of 200 lines will be available. The public is welcome to listen to the meeting by dialing 1–800–857–2850, and the passcode is 2622054. For Further Information Contact: KooWhang Chung, M.P.H., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027; Telephone: (404) 498–0730; Email: hicpac@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CE–20–001, Evaluating Practiced-based Programs, Policies, and Practices from CDC’s Rape Prevention Education Program; April 29–30, 2020, 8:30 a.m.– 5:30 p.m., EDT, in the original FRN. Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, Georgia 30305, which was published in the Federal Register on February 28, 2020, Volume 85, Number 40, pages 11992— 11993. The meeting is being amended to a virtual meeting. The meeting is closed to the public. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Building 106, MS S106–9, Atlanta, Georgia 30341, Telephone: (770) 488–6562, KLeeks@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–05258 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2020–05260 Filed 3–13–20; 8:45 am] lotter on DSKBCFDHB2PROD with NOTICES BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— GH20–001, Develop, Implement, and Evaluate Evidence-based, Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-Burden Settings; GH20–002, Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya; GH20–003, Conducting Public Health Research in Colombia; GH20–004, Conducting Public Health Research in Georgia; and GH20–005, Conducting Public Health Research in South America. Date: April 14–16, 2020. Time: 9:00a.m.–2:00p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Atlanta, Georgia 30329–4027, Telephone (404) 639–4796; HShoob@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–05263 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Sep<11>2014 18:29 Mar 13, 2020 Jkt 250001 PO 00000 Frm 00075 Fmt 4703 Sfmt 9990 E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Page 14946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05260]



[[Page 14946]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Healthcare 
Infection Control Practices Advisory Committee (HICPAC); March 5, 2020, 
from 9:00 a.m. to 5:00 p.m., EST, and March 6, 2020, from 9:00 a.m. to 
12:00 p.m., EST. Centers for Disease Control and Prevention, Global 
Communications, Center, Building 19, Auditorium B, 1600 Clifton Road 
NE, Atlanta, Georgia 30329-4027, and teleconference at 1-800-857-2850, 
passcode: 2622054, which was published in the Federal Register on 
January 6, 2020 Volume 85, Number 3, page 506.
    The meeting will now be held via teleconference only on March 5, 
2020, from 9:00 a.m. to 1:00 p.m., EST. A total of 200 lines will be 
available. The public is welcome to listen to the meeting by dialing 1-
800-857-2850, and the passcode is 2622054.
    For Further Information Contact: Koo-Whang Chung, M.P.H., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton 
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404) 
498-0730; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05260 Filed 3-13-20; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.